Boston Scientific Wins Guidant Takeover Battle, Ending Fierce Bidding War
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific faces the monumental task of integrating ICD-manufacturer Guidant following a $27.2 bil. acquisition victory over Johnson & Johnson on Jan. 25